This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.

Lithium Orotate

A low-dose, bioavailable form of lithium used as a nutritional supplement for mood stabilisation, neuroprotection, and support of grey matter volume and BDNF expression - distinct from high-dose prescription lithium carbonate.


Benefits

🍃

Anxiety & Calm

3.0 (editorial)

Log in to rate

🧠

Cognitive Enhancement

3.0 (editorial)

Log in to rate

Longevity

4.0 (editorial)

Log in to rate

💾

Memory

3.0 (editorial)

Log in to rate

☀️

Mood

4.5 (editorial)

Log in to rate

🛡️

Stress Relief

2.5 (editorial)

Log in to rate

What is Lithium Orotate?

Lithium orotate is a salt of lithium bonded to orotic acid, used as a low-dose nutritional supplement for mood support and neuroprotection. It is fundamentally different from prescription lithium carbonate, which is used at doses of 600-1,800 mg/day (delivering 113-339 mg of elemental lithium) for bipolar disorder. Lithium orotate is typically taken at 5-20 mg of elemental lithium per day - roughly 1/20th to 1/50th of the prescription dose. At these micro-doses, lithium acts as a trace mineral nutrient rather than a pharmaceutical, and it does not require the blood monitoring necessary for prescription lithium therapy.

The case for low-dose lithium as a neuroprotective nutrient is compelling. Epidemiological studies have found that populations with higher naturally occurring lithium levels in their drinking water have lower rates of suicide, violent crime, and dementia. A 2017 study published in JAMA Psychiatry found that higher lithium concentrations in drinking water were associated with reduced incidence of dementia across a Danish population of over 73,000 people. Lithium's neuroprotective mechanisms include inhibition of glycogen synthase kinase-3 (GSK-3) - an enzyme implicated in Alzheimer's pathology, tau phosphorylation, and neuronal apoptosis - and upregulation of BDNF, Bcl-2, and other neuroprotective factors. A 2015 meta-analysis in British Journal of Psychiatry confirmed that lithium is associated with increased grey matter volume, a finding that is unique among psychiatric agents.

  • GSK-3 inhibition: Lithium inhibits glycogen synthase kinase-3 beta, reducing tau phosphorylation, supporting neuronal survival, and promoting neuroplasticity
  • BDNF upregulation: Increases brain-derived neurotrophic factor expression, supporting neurogenesis and synaptic plasticity
  • Grey matter preservation: Multiple neuroimaging studies confirm that lithium increases grey matter volume in the hippocampus and prefrontal cortex
  • Bcl-2 induction: Upregulates the anti-apoptotic protein Bcl-2, protecting neurons from programmed cell death
  • Autophagy promotion: Lithium induces autophagy through mTOR-independent pathways, helping clear misfolded proteins and damaged organelles
  • Glutamate regulation: Modulates glutamatergic transmission to prevent excitotoxicity while maintaining healthy synaptic signalling
  • Typical supplement dosage: 5-20 mg of elemental lithium per day (from lithium orotate)
  • Common product strength: 120-130 mg of lithium orotate per capsule, providing approximately 5 mg of elemental lithium
  • Timing: Can be taken once daily, typically in the evening as lithium may promote relaxation
  • Onset: Mood-stabilising effects may be noticed within 1-2 weeks. Neuroprotective benefits are long-term
  • Not interchangeable with prescription lithium: Lithium orotate at supplement doses is not a substitute for prescription lithium carbonate in bipolar disorder. These are fundamentally different dosing regimens
  • Well tolerated at supplement doses: At 5-20 mg elemental lithium, the dose is far below the therapeutic range for prescription lithium (typically targeting serum levels of 0.6-1.2 mEq/L) and does not require blood monitoring
  • Kidney and thyroid: While high-dose prescription lithium requires kidney and thyroid monitoring, supplement-dose lithium orotate has not been associated with these effects. However, those with existing kidney or thyroid disease should consult their doctor
  • Drug interactions: May interact with prescription lithium, diuretics, ACE inhibitors, and NSAIDs. Consult a healthcare provider if taking these medications
  • Pregnancy: Lithium at any dose is potentially teratogenic (risk of Ebstein's anomaly). Avoid during pregnancy
  • Not for bipolar self-treatment: Bipolar disorder requires professional management. Lithium orotate supplements should not be used as a substitute for prescribed mood stabilisers

Natural Sources & Forms

  • Capsules: Widely available from supplement retailers, typically containing 120-130 mg lithium orotate (5 mg elemental lithium)
  • Drinking water: Lithium occurs naturally in drinking water at varying concentrations (0.1-100+ mcg/L depending on geology)
  • Food sources: Trace amounts found in grains, vegetables, and drinking water, but far below supplemental doses

Frequently Asked Questions

A low-dose, bioavailable form of lithium used as a nutritional supplement for mood stabilisation, neuroprotection, and support of grey matter volume and BDNF expression - distinct from high-dose prescription lithium carbonate.

The key benefits of Lithium Orotate include: Anxiety & Calm, Cognitive Enhancement, Longevity, Memory, Mood, Stress Relief.

GSK-3 inhibition: Lithium inhibits glycogen synthase kinase-3 beta, reducing tau phosphorylation, supporting neuronal survival, and promoting neuroplasticity BDNF upregulation: Increases brain-derived neurotrophic factor expression, supporting neurogenesis and synaptic plasticity Grey matter preservation: Multiple neuroimaging studies confirm that lithium increases grey matter volume in the hippocampus and prefrontal cortex Bcl-2 induction: Upregulates the anti-apoptotic protein Bcl-2, protecting neurons from programmed cell death Autophagy promotion: Lithium induces autophagy through mTOR-independent pathways, helping clear misfolded proteins and damaged organelles Glutamate regulation: Modulates glutamatergic transmission to prevent excitotoxicity while maintaining healthy synaptic signalling

Typical supplement dosage: 5-20 mg of elemental lithium per day (from lithium orotate) Common product strength: 120-130 mg of lithium orotate per capsule, providing approximately 5 mg of elemental lithium Timing: Can be taken once daily, typically in the evening as lithium may promote relaxation Onset: Mood-stabilising effects may be noticed within 1-2 weeks. Neuroprotective benefits are long-term Not interchangeable with prescription lithium: Lithium orotate at supplement doses is not a substitute for prescription lithium carbonate in bipolar disorder. These are fundamentally different dosing regimens

Well tolerated at supplement doses: At 5-20 mg elemental lithium, the dose is far below the therapeutic range for prescription lithium (typically targeting serum levels of 0.6-1.2 mEq/L) and does not require blood monitoring Kidney and thyroid: While high-dose prescription lithium requires kidney and thyroid monitoring, supplement-dose lithium orotate has not been associated with these effects. However, those with existing kidney or thyroid disease should consult their doctor Drug interactions: May interact with prescription lithium, diuretics, ACE inhibitors, and NSAIDs. Consult a healthcare provider if taking these medications Pregnancy: Lithium at any dose is potentially teratogenic (risk of Ebstein's anomaly). Avoid during pregnancy Not for bipolar self-treatment: Bipolar disorder requires professional management. Lithium orotate supplements should not be used as a substitute for prescribed mood stabilisers

Overall Rating

Log in to rate this nootropic.

Comments

Log in to leave a comment.

No comments yet. Be the first to share your experience!